FDA Inspection 1229603 — NeuroLogica Corporation

NeuroLogica Corporation — FEI 3004938766

The FDA completed an inspection of NeuroLogica Corporation on August 27, 2024 in Danvers, MA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 27, 2024
Fiscal Year
2024
Product Type
Devices
Project Area
Radiation Control and Health Safety Act
Location
Danvers, MA (United States)

Citations

IDCFRDescription
500721 CFR 1002.13Failure to submit
73221 CFR 803.50(a)(2)Individual Report of Malfunction